Charles River Laboratories International, Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2053
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:112
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Charles River Laboratories International, Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Charles River Laboratories International, Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Charles River Laboratories International, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Charles River Laboratories International, Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Charles River Laboratories International, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Charles River Laboratories International, Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Charles River Laboratories International, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 51
Corporate Venturing – Overview 51
Corporate Venturing – Deal reports 52
PARTNERSHIP 54
Partnership – Overview 54
Partnership – Deal reports 55
DIVESTMENTS 92
Divestments – Overview 92
Divestments – Deal reports 93
APPENDIX 102
Contact Us 102
About MarketLine Financial Deals Database 102
Deal Definition and Methodology 104
About MarketLine 111

List of Tables
Table 1: Charles River Laboratories International M&A volume and value trend (2014-YTD2018)
Table 2: Charles River Laboratories International M&A activity by geography (2014-YTD2018)
Table 3: Charles River Laboratories International corporate venturing volume and value trend (2014-YTD2018)
Table 4: Charles River Laboratories International corporate venturing by geography (2014-YTD2018)
Table 5: Charles River Laboratories International partnership volume and value trend (2014-YTD2018)
Table 6: Charles River Laboratories International partnership trend by key deal type (2014-YTD2018)
Table 7: Charles River Laboratories International divestments volume and value trend (2014-YTD2018)
Table 8: Charles River Laboratories International divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Charles River Laboratories International M&A volume and value trend (2014-YTD2018)
Figure 2: Charles River Laboratories International M&A activity by geography (2014-YTD2018)
Figure 3: Charles River Laboratories International corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Charles River Laboratories International corporate venturing by geography (2014-YTD2018)
Figure 5: Charles River Laboratories International partnership volume and value trend (2014-YTD2018)
Figure 6: Charles River Laboratories International partnership trend by key deal type (2014-YTD2018)
Figure 7: Charles River Laboratories International divestments volume and value trend (2014-YTD2018)
Figure 8: Charles River Laboratories International divestments by geography (2014-YTD2018)

★海外企業調査レポート[Charles River Laboratories International, Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adira Energy Ltd (ADENF):石油・ガス:M&Aディール及び事業提携情報
    Summary Adira Energy Ltd (Adira Energy) is an oil and gas company that acquires and explores crude oil and natural gas resource properties. The company undertakes oil and gas projects across Israel. It also holds interest in three offshore petroleum projects in Yitzhak, Gabriella, and Samuel. Adira …
  • Nanolek-製薬・医療分野:企業M&A・提携分析
    Summary Nanolek specializes in the production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines; drugs for treatment of leukemias, brain cancer, breast cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. Nanolek a …
  • Atlas Copco AB:企業の戦略・SWOT・財務情報
    Atlas Copco AB - Strategy, SWOT and Corporate Finance Report Summary Atlas Copco AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Expro Holdings UK 3 Ltd:企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Physiomics Plc (PYC)-製薬・医療分野:企業M&A・提携分析
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optim …
  • Concept Packaging Group:企業の戦略・SWOT・財務分析
    Concept Packaging Group - Strategy, SWOT and Corporate Finance Report Summary Concept Packaging Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tomey Corp:企業の戦略的SWOT分析
    Tomey Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Micron Technology Inc:企業の戦略・SWOT・財務分析
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Swallowfield PLC:企業の戦略・SWOT・財務情報
    Swallowfield PLC - Strategy, SWOT and Corporate Finance Report Summary Swallowfield PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • United Breweries Limited:企業の戦略・SWOT・財務情報
    United Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary United Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Lee Enterprises, Incorporated:企業の戦略・SWOT・財務情報
    Lee Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Lee Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Strongbridge Biopharma plc (SBBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Strongbridge Biopharma Plc (Strongbridge Biopharma), formerly Cortendo Plc is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hy …
  • GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment o …
  • Mesa Laboratories Inc (MLAB):医療機器:M&Aディール及び事業提携情報
    Summary Mesa Laboratories Inc (Mesa) is a medical device company that manufactures and markets validation and monitoring instruments. The company’s products include mesa biological indicators, DryCal gas flow calibrators, BGI ambient particulate sampling, DialyGuard dialysate meters, SureTorque cap …
  • Braxton Technologies LLC:企業の戦略・SWOT・財務分析
    Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report Summary Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AVI Limited:企業の戦略・SWOT・財務情報
    AVI Limited - Strategy, SWOT and Corporate Finance Report Summary AVI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Vermillion Inc (VRML):医療機器:M&Aディール及び事業提携情報
    Summary Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆